Furthermore, immunohistochemical staining confirmed an increased expression of caspase 3, a marker of cell apoptosis, within the tumor mass in TEFTS‐treated group compared to the control rats (Figure 4A, P = .0007). This evidence concerns the gene CASP3 and neoplasm.